Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (KR1020180088412) 아미노아졸 유도체

Office : Republic of Korea
Application Number: 1020187016201 Application Date: 09.12.2016
Publication Number: 1020180088412 Publication Date: 03.08.2018
Publication Kind : A
Prior PCT appl.: Application Number: ; Publication Number:WO2017099237 Click to see the data
IPC:
C07D 277/38
A61K 31/421
A61K 31/426
A61K 31/4439
A61K 31/4709
A61P 21/00
A61P 21/04
C07D 263/48
C07D 413/12
C07D 417/12
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
277
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
02
not condensed with other rings
20
having two or three double bonds between ring members or between ring members and non-ring members
32
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
38
Nitrogen atoms
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42
Oxazoles
421
1,3-Oxazoles, e.g. pemoline, trimethadione
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425
Thiazoles
426
1,3-Thiazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4427
containing further heterocyclic ring systems
4439
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
4709
Non-condensed quinolines containing further heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
21
Drugs for disorders of the muscular or neuromuscular system
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
21
Drugs for disorders of the muscular or neuromuscular system
04
for myasthenia gravis
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
263
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
02
not condensed with other rings
30
having two or three double bonds between ring members or between ring members and non-ring members
34
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
48
Nitrogen atoms not forming part of a nitro radical
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
413
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
02
containing two hetero rings
12
linked by a chain containing hetero atoms as chain links
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
417
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/196
02
containing two hetero rings
12
linked by a chain containing hetero atoms as chain links
Applicants: 데이진 화-마 가부시키가이샤
Inventors: 호소다 신노스케
우노키 겐
와타나베 히데카즈
사사키 고스케
시바타 준
요코야마 에미
호리에 교헤이
다카기 겐이치로
Agents: 특허법인코리아나
Priority Data: JP-P-2015-242065 11.12.2015 JP
Title: (KO) 아미노아졸 유도체
Abstract:
(KO) 하기 식으로 나타내는, 안드로겐 수용체의 활성 조절 작용을 갖는 화합물 또는 그 의약상 허용되는 염. X 는 S, O 를, Z 는 (R)-A-(CRR)-(CRR)- 를, A 는 아릴, 헤테로아릴을, R 은 알킬, 시클로알킬, 알케닐, 알키닐, 알콕시알킬, 아릴, 아릴알킬, 복소 고리, 복소 고리 알킬을, R 는, 수소, 할로겐, 알킬, 시클로알킬, 페닐을, R 은, 수소, 할로겐, 알킬, 시클로알킬, 알콕시알킬, 알케닐, 알키닐, 시클로알케닐, 아릴, 아릴알킬, 복소 고리, 복소 고리 알킬, 아실, 시클로알킬카르보닐, 벤조일, 스피로알킬, 아다만틸, 실릴, RRNCO- 를, R, R 는 수소, 할로겐, 알킬, 페닐, 시클로알킬을 나타낸다. a n 13 14 0-1 11 12 0-1 1 2 3 31 32 4 5 JPEG pct00523.jpg 36 57
Also published as:
MYPI 2018701082CA2997689AR107040AU2016366443JPWO2017099237IN201817009533
SG11201804359SIL259900CN108368068ID2018/09371EP3388425PH1/2018/500892
MX2018007000BR112018011389US20190031628WO/2017/099237